- Q4 2023 Prothena Corporation PLC Earnings Call TranscriptFeb 15, 2024$28.52 (+4.51%)Earnings
- Prothena Corporation PLC at Morgan Stanley Global Healthcare Conference TranscriptSep 11, 2023
- Prothena Corporation PLC at Jefferies Healthcare Conference TranscriptJun 08, 2023
- Prothena Corporation PLC at Bank of America Global Healthcare Conference TranscriptMay 09, 2023
- Prothena Corporation PLC at Stifel CNS Days (Virtual) TranscriptMar 28, 2023
- Q4 2022 Prothena Corporation PLC Earnings Call TranscriptFeb 23, 2023$50.9 (-2.30%)Earnings
- Prothena Corporation PLC at Morgan Stanley Global Healthcare Conference TranscriptSep 13, 2022
- Prothena Corporation PLC at Bank of America Healthcare Conference TranscriptMay 10, 2022
- Prothena Corporation PLC at Stifel CNS Days (Virtual) TranscriptMar 28, 2022
- Q4 2021 Prothena Corporation PLC Earnings Call TranscriptFeb 17, 2022$35.06 (-5.90%)Earnings
- Prothena Corporation PLC at Cantor Fitzgerald Global Healthcare Conference (Virtual) TranscriptSep 27, 2021
- Prothena Corporation PLC at Citi BioPharma Conference (Virtual) - Fireside Chat TranscriptSep 08, 2021
- Prothena Corporation PLC at RBC Capital Markets Global Healthcare Conference (Virtual) TranscriptMay 19, 2021
- Prothena Corporation PLC to Review Oral Presentations from AD/PD 2021 TranscriptMar 11, 2021
- Q4 2020 Prothena Corporation PLC Earnings Call TranscriptFeb 11, 2021$15.7 (-0.19%)Earnings
- Prothena Corporation PLC to Discuss AFFIRM-AL Study - Conference Call TranscriptFeb 02, 2021
- Prothena Corporation PLC - PRX004 Phase 1 Study Results TranscriptDec 09, 2020
- Prothena Corporation PLC to Discuss Results from Part 1 of the Phase 2 PASADENA Study - Conference Call TranscriptSep 15, 2020
- Q4 2019 Prothena Corporation PLC Earnings Call TranscriptFeb 12, 2020$13.51 (+4.49%)Earnings
- Prothena Corporation PLC to Discuss Results of the Phase 3 VITAL Amyloidosis Study - Conference Call TranscriptApr 18, 2019
- Prothena Corporation PLC at Barclays Global Healthcare Conference TranscriptMar 12, 2019
- Q4 2018 Prothena Corporation PLC Earnings Call TranscriptFeb 14, 2019$12.75Earnings
Prothena Corporation PLC - PRX004 Phase 1 Study Results Transcript
Ladies and gentlemen, thank you for standing by, and welcome to the Prothena conference call about PRX004 Phase I study results. (Operator Instructions) Please be advised that today's conference may be recorded. (Operator Instructions) I would now hand the conference over to your speaker today, Ms. Ellen Rose, Head of Communication. Please go ahead, ma'am.
Thank you, and hello, everyone, and welcome to Prothena's investor conference call to review the positive results from the Phase I study of PRX004 in patients with ATTR amyloidosis. Please review the press release we issued earlier today, which is available on our website at prothena.com.
On today's call, Dr. Gene Kinney, our President and Chief Executive Officer, will provide introductory remarks. Dr. Wagner Zago, our Chief Scientific Officer, will then speak about ATTR amyloidosis, its underlying pathophysiology and key elements of PRX004's preclinical research.
Today, we will also be joined by 2 physicians with expertise in
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)